The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics (Q36704645)

15 August 2017

1 reference

title

The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics (English)

1 reference

15 August 2017

1 reference

Michalis V Karamouzis

series ordinal

1

1 reference

15 August 2017

Panagiotis A Konstantinopoulos

series ordinal

2

1 reference

15 August 2017

Athanasios G Papavassiliou

series ordinal

3

1 reference

15 August 2017

publication date

10 January 2007

1 reference

Journal of Molecular Medicine

15 August 2017

published in

1 reference

15 August 2017

volume

85

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

427-436

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-006-0152-3

15 August 2017

exact match

0 references

cites work

Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-006-0152-3

Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-006-0152-3

Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-006-0152-3

Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice

21 January 2018

1 reference

12 December 2020

PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways

1 reference

12 December 2020

PIAS proteins and transcriptional regulation--more than just SUMO E3 ligases?

1 reference

12 December 2020

Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility

1 reference

12 December 2020

Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas

1 reference

12 December 2020

Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors

1 reference

12 December 2020

In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.

1 reference

12 December 2020

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor

1 reference

12 December 2020

STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3.

1 reference

12 December 2020

The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells

1 reference

12 December 2020

Negative regulation of cytokine signaling

1 reference

12 December 2020

SUMO-1 conjugation selectively modulates STAT1-mediated gene responses

1 reference

12 December 2020

Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation

1 reference

12 December 2020

Nuclear receptors as negative modulators of STAT3 in multiple myeloma

1 reference

12 December 2020

Cyclin-dependent kinase pathways as targets for cancer treatment

1 reference

12 December 2020

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling

1 reference

12 December 2020

Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma

1 reference

12 December 2020

Cell cycle alterations and lung cancer

1 reference

12 December 2020

Regulation of cytokine signaling pathways by PIAS proteins

1 reference

12 December 2020

Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.

1 reference

12 December 2020

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer

1 reference

12 December 2020

Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes

1 reference

12 December 2020

Epidermal growth factor receptor targeting in cancer

1 reference

12 December 2020

The IGF-1 network in lung carcinoma therapeutics

1 reference

12 December 2020

Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling

1 reference

12 December 2020

The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells

1 reference

12 December 2020

Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer

1 reference

12 December 2020

Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer

1 reference

12 December 2020

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma

1 reference

12 December 2020

Signal transducers and activators of transcription: insights into the molecular basis of oral cancer.

1 reference

12 December 2020

Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy

1 reference

12 December 2020

Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck

1 reference

12 December 2020

Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines

1 reference

12 December 2020

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

1 reference

12 December 2020

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

1 reference

12 December 2020

The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line

1 reference

12 December 2020

Are STATS arginine-methylated?

1 reference

12 December 2020

Inhibitors of cytokine signal transduction

1 reference

12 December 2020

Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Stat1 and SUMO modification

1 reference

12 December 2020

SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling

1 reference

12 December 2020

Focal adhesion kinase activates Stat1 in integrin-mediated cell migration and adhesion

1 reference

12 December 2020

The STATs of cancer--new molecular targets come of age

1 reference

12 December 2020

Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation

1 reference

12 December 2020

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

1 reference

12 December 2020

STAT3 as a therapeutic target in head and neck cancer

1 reference

12 December 2020

Coactivators in gene regulation by STAT5.

1 reference

12 December 2020

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer

1 reference

12 December 2020

Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways

1 reference

12 December 2020

Clinical development of SRC tyrosine kinase inhibitors in lung cancer

1 reference

12 December 2020

A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor

1 reference

12 December 2020

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

12 December 2020

The role of Janus kinases in haemopoiesis and haematological malignancy

1 reference

12 December 2020

Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.

1 reference

12 December 2020

Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells.

1 reference

12 December 2020

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival

1 reference

12 December 2020

Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.

1 reference

12 December 2020

Functional cross-modulation between SOCS proteins can stimulate cytokine signaling

1 reference

12 December 2020

Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

1 reference

12 December 2020

Targeting multiple signal transduction pathways in lung cancer.

1 reference

12 December 2020

Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation

1 reference

12 December 2020

Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma

1 reference

12 December 2020

The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells

1 reference

12 December 2020

Transcription factors and neoplasia: vistas in novel drug design.

1 reference

12 December 2020

Up-regulation of focal adhesion kinase in non-small cell lung cancer

1 reference

12 December 2020

10.1007/S00109-006-0152-3

Identifiers

DOI

1 reference

15 August 2017

1 reference